Table 2.
Roles of islet‐expressed chemokines in type 1 diabetes
| Receptor | Ligands | Ligand expression in islets | Role in T1D | |
|---|---|---|---|---|
| Animal models | Human | |||
| CCR2 | CCL2 | Mid 4 | Mid 60, 102, 109 | |
| CCR5 | CCL3, | Mid 63 | Low/neg 60 | |
| CCL4, | Mid 63 | Low/neg 60 | ||
| CCL5 | Mid 55 | Mid 55 | ||
| CCR7 | CCL19, | Mid 110 |
|
|
| CCL21 | Mid 110 | |||
| CXCR3 | CXCL9, | Mid 13, 55, 57 | Mid 55, 60 |
|
| CXCL10 | High 13, 55, 57, 64, 82 | High 55, 60 | ||
| CXCR4 | CXCL12 | Mid 89, 90, 91 | Mid 60 | |
| CXCR5 | CXCL13 | Mid 25, 111 | ||
| CXCR6 | CXCL16 | High 13 | ||
| M3 viral decoy receptor | CC chemokine ligands |
|
||
CCR = chemokine receptor; CCL = CC chemokine ligand; NOD = non‐obese diabetic; T1D = type 1 diabetes; CXCR = C‐X‐C chemokine receptor; CXCL = C‐X‐C motif) ligand 1; Idd = insulin‐dependent diabetes.